Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06481137 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reversibility of Cardiac Conduction Disturbances Following TAVI

Study acronym: TAVI-REVERSE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 1, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
The management of patients with conduction disturbances (CDs) after transcatheter aortic valve implantation (TAVI) is unclear, especially in those with de novo electrocardiographic CDs (ECG-CDs) such as left bundle branch block. In this study, the investigators will evaluate the incidence of retrogradation of infra-Hisian CDs in patients with de novo ECG-CDs and positive electrophysiological study (EPS) 3-7 days following TAVI. In addition, the investigators will evaluate the need for cardiac pacing and the incidence of clinical events in patients with negative EPS performed 3-7 days following TAVI. In this multicenter, longitudinal, prospective study, patients with clinical indication of EP study due to new-onset ECG-CDs after TAVI will be included. A permanent pacemaker will be implanted in patients with positive EPS and a second EPS will be performed in 30-45 days. Additionally, these patients will undergo 4-week continuous monitoring using the ePatch (Philips) long-term Holter recorder, to identify episodes of paroxysmal complete atrioventricular block. Patients with negative EP study will undergo clinical follow-up and continuous monitoring for 4 weeks.
Trial Details
NCT Number NCT06481137
Lead Sponsor Institut d'Investigació Biomèdica de Bellvitge
Collaborators: Hospital Universitari de Bellvitge, Hospital Universitario La Paz, Hospital Vall d'Hebron, Hospital Universitario Ramon y Cajal, Hospital Universitario A Coruna Spain, Hospital Clinico Universitario de Santiago, Hospital Universitario Central de Asturias, Hospital Universitario Marqués de Valdecilla, Hospital Clínico Universitario de Valladolid
Conditions
(from sponsor)
Aortic Stenosis, Transcatheter Aortic Valve Implantation, Conduction Disturbances
Related terms Aortic Valve Stenosis
Enrollment 209 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov